Entyvio

Made by

• Takeda

Active Ingredient

Vedolizumab (genetical recombination)

Prospectus

Approval date

2018/7/2

Treats

• Crohn disease
• Ulcerative colitis

Dosages

• Entyvio for I.V.Infusion 300mg. - 279573円／瓶